Shares of Eton Pharmaceuticals Inc. ETON jumped about 11% in premarket trading on Wednesday after the company said its experimental treatment for alcohol poisoning is being reviewed by the Food and Drug Administration. The regulator is expected to make a decision whether to approve the injection on or by June 27. Eton’s stock is down 25.6% over the past 12 months, while the broader S&P 500 SPX has declined 16.1%.
... Shares of Eton Pharmaceuticals Inc. ETON jumped about 11% in premarket trading on Wednesday after the company said its experimental treatment for alcohol poisoning is being reviewed by the Food and Drug Administration. The regulator is expected to make a decision whether to approve the injection on or by June 27. Eton’s stock is down 25.6% over the past 12 months, while the broader S&P 500 SPX has declined 16.1%.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Alzheimer’s drug lecanemab amid safety concernsReports of deaths potentially linked to the treatment have cast a shadow on what many hail as a landmark approval. As a former AD researcher, it appears that these two new treatments offer no advantage over tacrine - approved in 1994 for AD. Its successor, donepazil, also had similar efficacy. Both were approved with large Phase 3 trials. But profits. Huge. Why are studies on on lipid medicines like gemfibrizol, sp, being ignored for new drugs with safety issues? It seems to have promising results blocking ab without any real problems as it's well tolerated and already prescribed thousands of times. I guess it doesn't pay as well...
Source: Nature - 🏆 64. / 68 Read more »
FDA paused trials for experimental drugs more often in recent yearsThe Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years, a possible byproduct of newer medical technologies that offer promise but may pose additional risks. neiltyson patrickbetdavid
Source: dcexaminer - 🏆 6. / 94 Read more »